top of page
For most cost-effective consulting services:
Click here
Home
All News
Pharma
APAC
Brazil
Canada Pharma
China Pharma
Europe Pharma
India Pharma
Japan Pharma
North America
Saudi Arabia
US FDA Approvals
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
Germany Healthcare
Italy
United Kingdom Healthcare
APAC - Healthcare News
Brazil Healthcare
Healthcare Policies
Conferences
About
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
US_PayerNews
Radioligand therapy
NICE recommendations
Germany Healthcare Pharma News
HAS Assessment Outcomes
Neurology
Immunology
Blood Disorders
Oncology
Kidney Diseases
Cardiovascular Diseases
Infectious_Vaccines
Search
PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE
ipharmaservices
May 10, 2020
Novo Nordisk’s Rybelsus approved by European Union
ipharmaservices
Apr 5, 2020
NICE recommendation to manage symptoms of COVID-19
ipharmaservices
Apr 4, 2020
EMA approved GSK’s Trelegy Ellipta for asthma
ipharmaservices
Feb 28, 2020
EMA approved Mayzent (siponimod) for secondary progressive multiple sclerosis
ipharmaservices
Jan 27, 2020
European Commission approved AbbVie's Rinvoq (upadacitinib) for adults with moderate to severe RA
ipharmaservices
Dec 20, 2019
CHMP gave positive opinions for Beovu and Recarbrio
ipharmaservices
Dec 17, 2019
bottom of page